Skip to main content
. 2022 Mar 28;34(3):318–322. doi: 10.4103/tcmj.tcmj_240_21

Table 2.

Reference miRNAs expression in plasma samples

miRNAs HC (n=4) BT (n=14) AT (n=5) All (n=23)




Median (range) △Ct Median (range) △Ct Median (range) △Ct Median (range) △Ct
miR-16 21.77 (22.62-20.34) 2.28 22.15 (24.91-20.38) 4.53 22.16 (24.20-21.05) 3.15 22.00 (24.91-20.34) 4.57
miR-1228 26.83 (27.08-26.52) 0.56 26.36 (28.25-25.64) 2.61 26.84 (27.57-26.63) 0.94 26.80 (28.25-25.64) 2.61
cel-miR-39 14.58 (14.65-14.34) 0.31 14.95 (15.66-14.36) 1.30 15.01 (15.64-14.68) 0.96 14.94 (15.66-14.34) 1.32

HC: Healthy controls, BT: Before therapy of CRC patients, AT: After therapy of CRC patients,△Ct: Ctmaximum -Ctminimum, CRC: Colorectal cancer